Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0306 | 0.3181 | 1 |
Brugia malayi | celfurPC protein | 0.0406 | 0.4476 | 0.7803 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.2814 | 0.5 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0219 | 0.2055 | 0.1653 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0119 | 0.076 | 0.1032 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0187 | 0.1642 | 1 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0306 | 0.3181 | 0.262 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1868 | 0.1457 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0119 | 0.076 | 0.1032 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0317 | 0.3315 | 0.2766 |
Echinococcus multilocularis | 0.0406 | 0.4476 | 0.4022 | |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0119 | 0.076 | 0.1032 |
Loa Loa (eye worm) | proprotein convertase 2 | 0.0119 | 0.076 | 0.1325 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1868 | 0.1199 |
Brugia malayi | proprotein convertase 2 | 0.0317 | 0.3315 | 0.578 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0317 | 0.3315 | 0.2766 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0119 | 0.076 | 0.1032 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0504 | 0.5736 | 1 |
Echinococcus granulosus | furin | 0.0504 | 0.5736 | 0.5385 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0306 | 0.3181 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0504 | 0.5736 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.1868 | 0.1199 |
Loa Loa (eye worm) | hypothetical protein | 0.0198 | 0.1777 | 0.3097 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0504 | 0.5736 | 0.552 |
Schistosoma mansoni | subfamily S8B non-peptidase homologue (S08 family) | 0.0119 | 0.076 | 0.0293 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0119 | 0.076 | 0.1032 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0119 | 0.076 | 0.1032 |
Brugia malayi | endoprotease bli-4 precursor | 0.0504 | 0.5736 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1868 | 0.1457 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0306 | 0.3181 | 0.262 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.0317 | 0.3315 | 0.578 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.2239 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.